latest news releases from the newsroom
Generex Biotechnology Corp.
Generex Biotechnology Announces Successful Phase III Study Data for Generex Oral-lyn(tm)
WORCESTER, Mass., March 10, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced positive results following the review of the Phase III data for the Company's flagship product, Generex Oral-lyn, a proprietary oral insulin spray product designed to replace prandial injections of insulin.
Steiner Leisure Limited
Steiner Leisure Limited Announces New Agreement With Royal Caribbean International
NASSAU, The Bahamas, March 10, 2009 (GLOBE NEWSWIRE) -- Steiner Leisure Limited (Nasdaq:STNR) today announced that it has entered into a new agreement with Royal Caribbean International that extends the term of its original agreement through December 2013 and provides that Steiner will serve all Royal Caribbean vessels currently known to be coming into service through 2013.